141 related articles for article (PubMed ID: 38409918)
21. NAT10-mediated ac
Gao LP; Li TD; Yang SZ; Ma HM; Wang X; Zhang DK
Heliyon; 2024 May; 10(9):e30330. PubMed ID: 38726177
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of NAT10 as ac4C writer in diseases.
Xie L; Zhong X; Cao W; Liu J; Zu X; Chen L
Mol Ther Nucleic Acids; 2023 Jun; 32():359-368. PubMed ID: 37128278
[TBL] [Abstract][Full Text] [Related]
23. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma.
Pan Z; Bao Y; Hu M; Zhu Y; Tan C; Fan L; Yu H; Wang A; Cui J; Sun G
Cell Death Discov; 2023 Feb; 9(1):56. PubMed ID: 36765042
[TBL] [Abstract][Full Text] [Related]
24. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis.
Liu D; Kuang Y; Chen S; Li R; Su F; Zhang S; Qiu Q; Lin S; Shen C; Liu Y; Liang L; Wang J; Xu H; Xiao Y
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38724075
[TBL] [Abstract][Full Text] [Related]
25. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.
Yang Q; Lei X; He J; Peng Y; Zhang Y; Ling R; Wu C; Zhang G; Zheng B; Chen X; Zou B; Fu Z; Zhao L; Liu H; Hu Y; Yu J; Li F; Ye G; Li G
Adv Sci (Weinh); 2023 Aug; 10(23):e2300898. PubMed ID: 37328448
[TBL] [Abstract][Full Text] [Related]
26. NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells.
Dalhat MH; Mohammed MRS; Alkhatabi HA; Rehan M; Ahmad A; Choudhry H; Khan MI
Clin Transl Med; 2022 Sep; 12(9):e1045. PubMed ID: 36149760
[TBL] [Abstract][Full Text] [Related]
27. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.
Wei W; Zhang S; Han H; Wang X; Zheng S; Wang Z; Yang C; Wang L; Ma J; Guo S; Wang J; Liu L; Choe J; Lin S
Cell Rep; 2023 Jul; 42(7):112810. PubMed ID: 37463108
[TBL] [Abstract][Full Text] [Related]
28. Ac4C Enhances the Translation Efficiency of Vegfa mRNA and Mediates Central Sensitization in Spinal Dorsal Horn in Neuropathic Pain.
Xu T; Wang J; Wu Y; Wu JY; Lu WC; Liu M; Zhang SB; Xie D; Xin WJ; Xie JD
Adv Sci (Weinh); 2023 Dec; 10(35):e2303113. PubMed ID: 37877615
[TBL] [Abstract][Full Text] [Related]
29. NAT10 mediated ac4C acetylation driven m
Mei Z; Shen Z; Pu J; Liu Q; Liu G; He X; Wang Y; Yue J; Ge S; Li T; Yuan Y; Yang L
Cell Commun Signal; 2024 Jan; 22(1):51. PubMed ID: 38233839
[TBL] [Abstract][Full Text] [Related]
30. NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
Chen X; Hao Y; Liu Y; Zhong S; You Y; Ao K; Chong T; Luo X; Yin M; Ye M; He H; Lu A; Chen J; Li X; Zhang J; Guo X
Adv Sci (Weinh); 2023 Nov; 10(32):e2302705. PubMed ID: 37818745
[TBL] [Abstract][Full Text] [Related]
31. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression.
Zong G; Wang X; Guo X; Zhao Q; Wang C; Shen S; Xiao W; Yang Q; Jiang W; Shen J; Wan R
Exp Cell Res; 2023 Jul; 428(2):113620. PubMed ID: 37156457
[TBL] [Abstract][Full Text] [Related]
32. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Feng Z; Li K; Qin K; Liang J; Shi M; Ma Y; Zhao S; Liang H; Han D; Shen B; Peng C; Chen H; Jiang L
J Hematol Oncol; 2022 Aug; 15(1):112. PubMed ID: 35978332
[TBL] [Abstract][Full Text] [Related]
33. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
Zhang H; Lu R; Huang J; Li L; Cao Y; Huang C; Chen R; Wang Y; Huang J; Zhao X; Yu J
Cell Mol Life Sci; 2024 Feb; 81(1):73. PubMed ID: 38308713
[TBL] [Abstract][Full Text] [Related]
34. NAT10 Maintains
Lin J; Xiang Y; Huang J; Zeng H; Zeng Y; Liu J; Wu T; Liang Q; Liang X; Li J; Zhou C
Front Endocrinol (Lausanne); 2022; 13():907286. PubMed ID: 35937804
[No Abstract] [Full Text] [Related]
35. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges.
Luo J; Cao J; Chen C; Xie H
Biochem Pharmacol; 2023 Jul; 213():115628. PubMed ID: 37247745
[TBL] [Abstract][Full Text] [Related]
36. NAT10 promotes renal ischemia-reperfusion injury via activating NCOA4-mediated ferroptosis.
Shen J; Sun Y; Zhuang Q; Xue D; He X
Heliyon; 2024 Jan; 10(2):e24573. PubMed ID: 38312597
[TBL] [Abstract][Full Text] [Related]
37. NAT10/CEBPB/vimentin signalling axis promotes adenoid cystic carcinoma malignant phenotypes in vitro.
Fu M; Gao Q; Xiao M; Sun XY; Li SL; Ge XY
Oral Dis; 2024 Jan; ():. PubMed ID: 38287502
[TBL] [Abstract][Full Text] [Related]
38. NAT10 promotes osteogenic differentiation of periodontal ligament stem cells by regulating VEGFA-mediated PI3K/AKT signaling pathway through ac4C modification.
Cui Z; Xu Y; Wu P; Lu Y; Tao Y; Zhou C; Cui R; Li J; Han R
Odontology; 2023 Oct; 111(4):870-882. PubMed ID: 36879181
[TBL] [Abstract][Full Text] [Related]
39. The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review.
Jin G; Xu M; Zou M; Duan S
Mol Ther Nucleic Acids; 2020 Jun; 20():13-24. PubMed ID: 32171170
[TBL] [Abstract][Full Text] [Related]
40. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.
Shrimp JH; Jing Y; Gamage ST; Nelson KM; Han J; Bryson KM; Montgomery DC; Thomas JM; Nance KD; Sharma S; Fox SD; Andressen T; Sinclair WR; Wu H; Allali-Hassani A; Senisterra G; Vedadi M; Lafontaine D; Dahlin JL; Marmorstein R; Walters MA; Meier JL
ACS Med Chem Lett; 2021 Jun; 12(6):887-892. PubMed ID: 34141066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
